24-1230·CIVIL
Pharmaceutical Coalition for Patient Access v. United States of America; Department of Health and Human Services; Office of the Inspector General, U.s. Department of Health and Human Services; Christi A. Grimm
Affirmed
Status
- Scheduled
- Argued
- Opinion Issued (current)
Question Presented
Challenge to OIG's advisory opinion finding that plan to help financially needy cancer patients afford oncological Pharmaceutical Coalition for Patient Access drugs would violate anti-kickback statute.
Argument Date
October 30, 2024
Argument Time
9:30 a.m.
Panel
VI
Courtroom
Tan Courtroom (Room 223)
Lower Court Judge
Young
Panel
Chief Judge Diaz
Judge King
Judge Flanagan*
Citation
CasePharmaceutical Coalition for Patient Access v. United States of America; Department of Health and Human Services; Office of the Inspector General, U.s. Department of Health and Human Services; Christi A. Grimm, No. 24-1230 (4th Cir. Jan. 23, 2025)
PanelDiaz, C.J., King & Flanagan, JJ.
Arguing Counsel
Panel That Day
3 of 3 cases argued October 30, 2024 before this panel have been decided.
Decided
22-4658
United States v. Alante Nelson
Authored by Judge King
23-1672
Andre Le Doux, V v. Western Express, Inc.
Authored by Chief Judge Diaz
24-1230· This case
Pharmaceutical Coalition for Patient Access v. United States of America; Department of Health and Human Services; Office of the Inspector General, U.s. Department of Health and Human Services; Christi A. Grimm
Authored by Judge Flanagan*
Opinions
- Read opinion ↗January 23, 2025Majorityby Flanagan
Disposition
Affirmed
January 23, 2025